Finance

Lists
HLS:TSE
HLS Therapeutics Inc
CA$3.65
-0.54%
(-0.020) 1D
Nov 20, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for HLS...
Open
CA$3.67
High
CA$3.71
Low
CA$3.59
Mkt. cap
110.11M
Avg. vol.
49.69K
Volume
96.01K
52-wk high
CA$5.25
52-wk low
CA$3.51
EPS
-CA$0.32
Beta
0.49
Shares outstanding
30.94M
No. of employees
85
Open
CA$3.67
High
CA$3.71
Low
CA$3.59
Mkt. cap
110.11M
Avg. vol.
49.69K
Volume
96.01K
52-wk high
CA$5.25
52-wk low
CA$3.51
EPS
-CA$0.32
Beta
0.49
Shares outstanding
30.94M
No. of employees
85
News stories
From web sources and news partners
About HLS Therapeutics Inc
CEO-
Employees85
Founded2014
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 12, 2026
Fiscal period
Q3 2026
-$0.07 / -$0.07
0.00%miss
Revenue / Est. (USD)
14.16M / 14.97M
-5.42%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
15.20M
12.86M
14.67M
14.16M
Cost of goods sold
4.28M
4.19M
4.56M
4.11M
Cost of revenue
4.28M
4.19M
4.56M
4.11M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.21M
5.21M
5.45M
5.09M
Operating expense
10.68M
10.89M
11.27M
10.84M
Total operating expenses
14.96M
15.08M
15.83M
14.94M
Operating income
237.00K
-2.22M
-1.16M
-790.00K
Other non operating income
-517.00K
-87.00K
-73.00K
-544.00K
EBT including unusual items
-1.98M
-2.30M
-1.01M
-2.24M
EBT excluding unusual items
-1.98M
-2.30M
-1.01M
-2.24M
Income tax expense
-647.00K
2.00K
13.00K
-9.00K
Effective tax rate
32.64%
-0.09%
-1.29%
0.40%
Other operating expenses
-
-
-
-
Net income
-1.34M
-2.30M
-1.02M
-2.23M
Net profit margin
-8.79%
-17.86%
-6.95%
-15.73%
Earnings per share
-0.04
-0.07
-0.03
-0.07
Interest and investment income
18.00K
12.00K
4.00K
49.00K
Interest expense
-897.00K
-801.00K
-748.00K
-757.00K
Net interest expenses
-879.00K
-789.00K
-744.00K
-708.00K
Depreciation and amortization charges
5.46M
5.54M
5.53M
5.51M
EBITDA
5.18M
3.32M
4.37M
4.72M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps